315 related articles for article (PubMed ID: 11254689)
1. Multiple antigen-specific processing pathways for activating naive CD8+ T cells in vivo.
Norbury CC; Princiotta MF; Bacik I; Brutkiewicz RR; Wood P; Elliott T; Bennink JR; Yewdell JW
J Immunol; 2001 Apr; 166(7):4355-62. PubMed ID: 11254689
[TBL] [Abstract][Full Text] [Related]
2. Inefficient cross-presentation limits the CD8+ T cell response to a subdominant tumor antigen epitope.
Otahal P; Hutchinson SC; Mylin LM; Tevethia MJ; Tevethia SS; Schell TD
J Immunol; 2005 Jul; 175(2):700-12. PubMed ID: 16002665
[TBL] [Abstract][Full Text] [Related]
3. Leishmania antigens are presented to CD8+ T cells by a transporter associated with antigen processing-independent pathway in vitro and in vivo.
Bertholet S; Goldszmid R; Morrot A; Debrabant A; Afrin F; Collazo-Custodio C; Houde M; Desjardins M; Sher A; Sacks D
J Immunol; 2006 Sep; 177(6):3525-33. PubMed ID: 16951311
[TBL] [Abstract][Full Text] [Related]
4. Loading of MHC class I and II presentation pathways by exogenous antigens: a quantitative in vivo comparison.
Storni T; Bachmann MF
J Immunol; 2004 May; 172(10):6129-35. PubMed ID: 15128799
[TBL] [Abstract][Full Text] [Related]
5. Partially TAP-independent protection against Listeria monocytogenes by H2-M3-restricted CD8+ T cells.
Rolph MS; Kaufmann SH
J Immunol; 2000 Oct; 165(8):4575-80. PubMed ID: 11035099
[TBL] [Abstract][Full Text] [Related]
6. Furin-processed antigens targeted to the secretory route elicit functional TAP1-/-CD8+ T lymphocytes in vivo.
Medina F; Ramos M; Iborra S; de León P; Rodríguez-Castro M; Del Val M
J Immunol; 2009 Oct; 183(7):4639-47. PubMed ID: 19752221
[TBL] [Abstract][Full Text] [Related]
7. Prime-boost with alternating DNA vaccines designed to engage different antigen presentation pathways generates high frequencies of peptide-specific CD8+ T cells.
Radcliffe JN; Roddick JS; Friedmann PS; Stevenson FK; Thirdborough SM
J Immunol; 2006 Nov; 177(10):6626-33. PubMed ID: 17082574
[TBL] [Abstract][Full Text] [Related]
8. A low affinity TCR ligand restores positive selection of CD8+ T cells in vivo.
Stefanski HE; Mayerova D; Jameson SC; Hogquist KA
J Immunol; 2001 Jun; 166(11):6602-7. PubMed ID: 11359813
[TBL] [Abstract][Full Text] [Related]
9. TAP-independent presentation of CTL epitopes by Trojan antigens.
Lu J; Wettstein PJ; Higashimoto Y; Appella E; Celis E
J Immunol; 2001 Jun; 166(12):7063-71. PubMed ID: 11390450
[TBL] [Abstract][Full Text] [Related]
10. The adjuvant effects of Mycobacterium tuberculosis heat shock protein 70 result from the rapid and prolonged activation of antigen-specific CD8+ T cells in vivo.
Harmala LA; Ingulli EG; Curtsinger JM; Lucido MM; Schmidt CS; Weigel BJ; Blazar BR; Mescher MF; Pennell CA
J Immunol; 2002 Nov; 169(10):5622-9. PubMed ID: 12421941
[TBL] [Abstract][Full Text] [Related]
11. Antigen targeting to CD11b allows efficient presentation of CD4+ and CD8+ T cell epitopes and in vivo Th1-polarized T cell priming.
Schlecht G; Loucka J; Najar H; Sebo P; Leclerc C
J Immunol; 2004 Nov; 173(10):6089-97. PubMed ID: 15528345
[TBL] [Abstract][Full Text] [Related]
12. The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens.
Haicheur N; Bismuth E; Bosset S; Adotevi O; Warnier G; Lacabanne V; Regnault A; Desaymard C; Amigorena S; Ricciardi-Castagnoli P; Goud B; Fridman WH; Johannes L; Tartour E
J Immunol; 2000 Sep; 165(6):3301-8. PubMed ID: 10975847
[TBL] [Abstract][Full Text] [Related]
13. Bacterial proteins can be processed by macrophages in a transporter associated with antigen processing-independent, cysteine protease-dependent manner for presentation by MHC class I molecules.
Campbell DJ; Serwold T; Shastri N
J Immunol; 2000 Jan; 164(1):168-75. PubMed ID: 10605008
[TBL] [Abstract][Full Text] [Related]
14. Tolerant CD8 T cells induced by multiple injections of peptide antigen show impaired TCR signaling and altered proliferative responses in vitro and in vivo.
Dubois PM; Pihlgren M; Tomkowiak M; Van Mechelen M; Marvel J
J Immunol; 1998 Nov; 161(10):5260-7. PubMed ID: 9820498
[TBL] [Abstract][Full Text] [Related]
15. Induction of MHC class I presentation of exogenous antigen by dendritic cells is controlled by CD4+ T cells engaging class II molecules in cholesterol-rich domains.
Machy P; Serre K; Baillet M; Leserman L
J Immunol; 2002 Feb; 168(3):1172-80. PubMed ID: 11801652
[TBL] [Abstract][Full Text] [Related]
16. IFN-alpha beta promote priming of antigen-specific CD8+ and CD4+ T lymphocytes by immunostimulatory DNA-based vaccines.
Cho HJ; Hayashi T; Datta SK; Takabayashi K; Van Uden JH; Horner A; Corr M; Raz E
J Immunol; 2002 May; 168(10):4907-13. PubMed ID: 11994440
[TBL] [Abstract][Full Text] [Related]
17. Cross-priming of T cell responses by synthetic microspheres carrying a CD8+ T cell epitope requires an adjuvant signal.
Boisgérault F; Rueda P; Sun CM; Hervas-Stubbs S; Rojas M; Leclerc C
J Immunol; 2005 Mar; 174(6):3432-9. PubMed ID: 15749877
[TBL] [Abstract][Full Text] [Related]
18. The role of T cell antagonism and original antigenic sin in genetic immunization.
Singh RA; Rodgers JR; Barry MA
J Immunol; 2002 Dec; 169(12):6779-86. PubMed ID: 12471109
[TBL] [Abstract][Full Text] [Related]
19. In vivo cross-presentation of a soluble protein antigen: kinetics, distribution, and generation of effector CTL recognizing dominant and subdominant epitopes.
Nelson D; Bundell C; Robinson B
J Immunol; 2000 Dec; 165(11):6123-32. PubMed ID: 11086045
[TBL] [Abstract][Full Text] [Related]
20. Targeting tumour cells with defects in the MHC Class I antigen processing pathway with CD8+ T cells specific for hydrophobic TAP- and Tapasin-independent peptides: the requirement for directed access into the ER.
Aladin F; Lautscham G; Humphries E; Coulson J; Blake N
Cancer Immunol Immunother; 2007 Aug; 56(8):1143-52. PubMed ID: 17143611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
